Therapeutics 2 Exam1 Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
ATGAM | Polyclonal Antibody - Depleting Induction These antibodies coat the T-cells in the blood; these coated T-cells are then destroyed by the complement system |
Thymoglobulin | Polyclonal Antibody - Depleting Induction These antibodies coat the T-cells in the blood; these coated T-cells are then destroyed by the complement system |
Basiliximab | Simulect - antibody against CD25 (IL-2 receptor) which will prevent activated T lymphocyte proliferation |
CAMPATH-1H | Alemtuzumab - Monoclonal antibody - depleting Induction - acts directly at CD52 on all lymphocytes, NK cells, macrophages, monocytes, and granulocytes - activates complement and antibody dependent cellular cytotoxicity and lysis |
Azathioprine | Maintenance Immunosuppression - Antiproliferative drug -prodrug of 6-mercaptopurine - inhibition of DNA and RNA synthesis to inhibit lymphocyte proliferation - not first line! |
Mycophenolate mofetil | Cell-Cept - maintenance immunosuppression - prodrug of mycophenolic acid - inhibits IMPDH which interferes with purine metabolism required for lymphocyte development |
Myfortic | EC-MPS - enteric coated mycophenolic acid sodium - maintenance immunosuppression - inhibits IMPDH which interferes with purine metabolism required for lymphocyte development |
Cyclosporin | CYA - Neoral, Gengraft, Sandimmune, Sangcya - maintenance immunosuppression - inhibits calcium dependent calcineurin |
MOA for Calcineurin Inhibitors (CYA and TAC) | Inhibition of calcium dependent calcineurin - results in reduction of transcription of cytokine jeans needed for T-cell activation (bind calcineurin hindering the phosphatase site resoling in no activation of NFAT and inhibition of IL-2 production |
Neoral | CYA microemulsion to improve the variable GI absorption |
Prednisone or Methyprednisolone | General immunosuppressive with proposed action to inhibit IL-1 and IL-2 which decreases activation and proliferation of T-cells |
Sirolimus | (Rapamycin-RAPA) - Rapamune - inhibits m-TOR -> IL-2 timulates m-TOR to activate kinase enzymes that promote cell division - used to prevent acute rejection in kidney transplant with CYA and steroids (maintenance immunosuppression) - long half life |
Everolimus | (EVER) - mTOR inhibitor - used to prevent rejection in kedney transplant - dosed with CYA and glucocorticoids ((maintenance immunosuppression) |
Balatacept | Nulojix - selective co-stimulation blocker (signal 2) - prevents CD80 or CD86 on APC from interacting with CD28 on T-cells - inhibits T cell activation (maintenance immunosuppression) |
Induction Immunosuppression Regimens (High Risk Patients) | Thymoglobulin or Alemtuzumab or Basiliximab with MMF and glucocorticoids |
Induction Immunosuppression Regimens (Low Risk Patients) | Basiliximab (Simulect) |
Maintenance Immunosuppression Regimens & target troughs | TAC + MMF or EC-MPS + PRED (TAC trough 9-15 ng/mL for first 3 months) CYA + MMF or EC-MPS + PRED (CYA trough 150-300 ng/mL for 1st 3 months) |
Minimized Protocols (Steroid Avoidance) Maintenance Immunosuppression Regimens & Target toughs | Low dose TAC + regular dose MMF or EC-MPS (TAC tough 8-12ng/mL for first 3 months; then progress to 3-7 ng/mL) Low dose CYA +regular dose MMF or EC-MPS (CYA tough 100-200 ng/mL for first 3 months; progress to 50-100 ng/mL) |
Acute Cellular Rejection Medications | High Dose Methylprednisolone for 3 to 5 days Murine Monoclonal Antibody (Orthodone OKT3) Thymoglobulin - polyclonal AB Alemtuzumab (Campath) - moAB |
Humoral Rejection | Plasmapheresis: remove pathogenic immunoglobulins IV immunoglobulin (IVIG): inhibition/suppress AB production Rituximab - for refractory cases - humanized CD20 MoAB to deplete B cells |
Methotrexate (MTX) | Used for RA - immunosuppressant that inhibits dihydrofolate reductace which --> inhibits lymphocyte proliferation Must always be supplemented with folic acid BBW: pregnancy, concomitant NSAID use, hepatotoxicity |
Leflunomide (LEF) | Used for RA - inhibits dihydroorotate dehydrogenase which intern inhibits lymphocyte proliferation BBW: pregnancy, hepatic disease |
Hydroxychloroquine (HCQ) | Used for RA - inhibits migration of neutrophils and eosinophils, rheumatoid factor, acute phase reactants, and inhibits prostaglanding synthesis BBW: ocular disease |
Sulfasalazine (SSZ) | Used for RA BBW: G6PD dificiency, GI obstructions, porphyria |
Tofacitinib | Xeljanz - Used for RA - janus kinase inhibitor, prevents immune function and activation BBW: infection, secondary malignancy |
Adalimumab | Humira - Used for RA inhibits TNA-a SC every 2 weeks (every week if not on MTX) Usually used with MTX |
Certolizumab pegol | Cimzia - Used for RA Inhibits TNA-a SC every 2 weeks Not given with MTX |
Etanercept | Enbrel - used for RA inhibits TNF-a SC every week Contraindications: Sepsis Not used with MTX |
Golimumab | Simponi - Used for RA Inhibits TNF-a SC every month BBW: invasive fungal infections, TB Given with MTX |
Infliximab | Remicade - Used for RA inhibits TNF-a Dose every 8 weeks with MTX Contraindications CHF Class III-V |
Rituximab | Rituxan - Used for RA Binds to B-lymphocyte CD-20 surface antigens Dose IV every 16-24 weeks (commonly given with methlyprednisolone to reduce injection site reaction |
Abatacept | Orencia - Used for RA Selective co-stimulation modulator (inhibits Tcell activation) Weight based IV every month |
Anakinra | Kineret - Used for RA Inhibits IL-1 type I receptors Dosed SC daily Contraindication: hypersensitivity to E. coli |
Tocilizumab | Actermra - Used for RA inhibits IL-6 receptors Dose IV monthly (with or without MTX) BBW: serious risk of infection |
RA Triple Therapy | MTX + HCQ + SSZ |
Gout Acute Attack | High-dose NSAID Oral colchicine Corticosteroids |
Gout Long Term treatment | Allopurinol Febuxostat Probenecid |
Allopurinol | Xanthine oxidase inhibitor - used for Gout Underexcreters and overproducers Renal dosing limits Interaction with Warfarin, antiacids, and amoxicillin |
Febuxostat | Xanthine oxidase inhibitors - Used for Gout Useful in underexcreters and overproducers Expensive |
Probenecid | Uricosuric - used in Gout Underexcreters only Nephrolithiasis (must drink a lot to prevent this) |
Off label Uricosurics | losartan, fenofibrate |
Created by:
Newby549
Popular Pharmacology sets